RAMB - Dezembro

lara

APHS

900

ssoc

ras

2016; 62(9):895-900

21.

Miehlke S, Madisch A, Karimi D, Wonschik S, Kuhlisch E, Beckmann R, et al.

Budesonide is effective in treating lymphocytic colitis: a randomized double-

blind placebo: controlled study. Gastroenterology. 2009; 136(7):2092-100.

22.

Pardi DS, Loftus EV, Tremaine WJ, Sandborn WJ. A randomized double-

blind, placebo controlled trial of budesonide for the treatment of active

lymphocytic colitis. Gastroenterology. 2009; 136(5 suppl 1):A519-20.

23.

Bonderup OK, Hansen JB, Teglbjaerg PS, Chrustensen LA. Fallingborg JF.

Long-term budesonide treatment of collagenous colitis: a randomised,

double-blind, placebo-controlled trial. Gut. 2009; 58(1):68-72.

24.

Miehlke S, Madisch A, Bethke B, Morgner A, Kuhlisch E, Henker C, et al.

Oral budesonide for maintenance treatment of collagenous colitis: a

randomized, double-blind, placebo-controlled trial. Gastroenterology. 2008;

135(5):1510-6.

25.

Stewart MJ, Seow CH, Storr MA. Prednisolone and budesonide for short-

and long-term treatment of microscopic colitis: systematic review and meta-

analysis. Clin Gastroenterol Hepatol. 2011; 9(10):881-90.

26. Gentile NM, Abdalla AA, Khanna S, Smyrk TC, Tremaine WJ, Faubion WA,

et al. Outcomes of patients withmicroscopic colitis treated with corticosteroids:

a population-based study. Am J Gastroenterol. 2013; 108(2):256-9.

27. Olesen M, Eriksson S, Bohr J, Järnerot G, Tysk C. Lymphocytic colitis: a

retrospective clinical study of 199 Swedish patients. Gut. 2004; 53(4):536-41.

28.

Bohr J, Tysk C, Eriksson S, Abrahamsson H, Järnerot G. Collagenous colitis:

a retrospective study of clinical presentation and treatment in 163 patients.

Gut. 1996; 39(6):846-51.

29.

Pardi DS, Ramnath VR, Loftus EV, Tremaine WJ, Sandborn WJ. Lymphocytic

colitis: clinical features, treatment, and outcomes. Am J Gastroenterol. 2002;

97(11):2829-33.

30.

Munck LK, Kieldsen J, Philipsen E, Fischer Hansen B. Incomplete remission

with short-term prednisolone treatment in collagenous colitis: a randomized

study. Scand J Gastroenterol. 2003; 38(6):606-10.

31. Chande N, MacDonald JK, McDonald JWD. Interventions for treating

lymphocytic colitis. Cochrane Database Syst Rev. 2008; 16(2):CD006096.

32. Tangri V, Chande N. Microscopic colitis: a update. J Clin Gastroenterol.

2009; 43(4):293-6.

33. Calabrese C, Fabbri A, Areni A, Scialpi C, Di Febo G. Mesalazine with or

without cholestyramine in the treatment of microscopic colitis: randomized

controlled trial. J Gastroenterol Hepatol. 2009; 22(6):809-14.

34. Wildt S, Munck LK, Vinter-Jensen L, Fischer Hansen B, Nordgaard-Lassen

I, Christensen S, et al. Probiotic treatment of collagenous colitis: a

randomized, double-blind, placebo-controlled trial with Lactobacillus

acidophilusand Bifidobacterium animalis subsp. Lactis. Inflamm Bowel

Dis. 2006; 12(5):395-401.

35. Goff JS, Barnett JL, Pelke T, Appelman HD. Collagenous colitis: histopathology

and clinical course. Am J Gastroenterol. 1997; 92(1):57-60.

36.

Bonner GF, Petras RE, Cheong DM, Grewal ID, Breno S, Ruderman WB.

Short- and long-term follow-up of treatment for lymphocytic and collagenous

colitis. Inflamm Bowel Dis. 2000; 6(2):85-91.